Liminal BioSciences Inc. (NASDAQ: LMNL) rose 51.7% to $6.10 in pre-market trading. Liminal BioSciences reported the FDA approval for its Biologics License Application for Ryplazim. Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) rose 24.4% to $4.23 in pre-market trading after surging 24% on Friday. Evofem Biosciences, Inc. (NASDAQ: EVFM) rose 12.7% to $0.9755 in pre-market trading. Evofem Biosciences, last month, priced its 50 million shares common stock offering at $1 per share. MicroVision, Inc. (NASDAQ: MVIS) shares rose 11.6% to $22.59 in pre-market trading after climbing 12% on Friday. Tellurian Inc. (NASDAQ: TELL) shares rose 11.6% to $5.50 in pre-market trading. Tellurian, last week, announced it signed a 10-year LNG agreement for 3 mtpa with Vitol. Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 10.3% to $10.27 in pre-market trading. Celyad Oncology SA (NASDAQ: CYAD) rose 10.2% to $6.07 in pre-market trading. Celyad Oncology, last month, announced initial clinical data from the Phase 1 IMMUNICY-1 trial evaluating CYAD-211 in patients with relapsed or refractory multiple myeloma. HC2 Holdings, Inc. (NASDAQ: HCHC) rose 10% to $4.74 in pre-market trading. HC2 Holdings Director disclosed purchase of 26,455 shares at an average price of $4.00. Veritone, Inc. (NASDAQ: VERI) rose 9.8% to $19.76 in pre-market trading. Bionano Genomics, Inc. (NASDAQ: BNGO) rose 8.9% to $7.48 in pre-market trading after gaining 9% on Friday. Naked Brand Group Limited (NASDAQ: NAKD) rose 8.7% to $0.7586 in pre-market trading after dropping 15% on Friday. Urban One, Inc. (NASDAQ: UONE) rose 8.4% to $14.15 in pre-market trading. Sundial Growers Inc. (NASDAQ: SNDL) rose 8.3% to $1.18 in pre-market trading after dropping over 15% on Friday. Universe Pharmaceuticals INC (NASDAQ: UPC) shares rose 7.4% to $3.20 in pre-market trading after declining around 4% on Friday. Washington Prime Group Inc. (NYSE: WPG) rose 6% to $5.11 in pre-market trading after jumping 14% on Friday. AMC Entertainment Holdings, Inc. (NYSE: AMC) rose 4.2% to $49.90 in pre-market trading after dropping around 7% on Friday. As per a Reuters report, Wall Street traders are continuing to bet against the stock, although have reduced their reliance on short selling.
Find out what’s going on in today’s market and bring any questions you have to Benzinga’s PreMarket Prep.
Purple Biotech Ltd. (NASDAQ: PPBT) fell 14.7% to $5.05 in pre-market trading. Purple Biotech recently announced new data from the first dose level cohort of its ongoing Phase 1/2 trial evaluating NT219 in various solid tumors. ShiftPixy, Inc. (NASDAQ: PIXY) fell 10.1% to $3.10 in pre-market trading after jumping 21% on Friday. American Financial Group, Inc. (NYSE: AFG) fell 9.8% to $126.48 in pre-market trading. Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 9.4% to $3.28 in pre-market trading. Fuel Tech, Inc. (NASDAQ: FTEK) fell 7.5% to $2.71 in pre-market trading after surging over 36% on Friday. The company, last month, reported quarterly results. Windtree Therapeutics, Inc. (NASDAQ: WINT) shares fell 7.1% to $2.51 in pre-market trading. Windtree Therapeutics shares jumped 36% on Friday after Oppenheimer initiated coverage on the stock with an Outperform rating and an $8 price target.
© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.